Altrartis Therapeutics raises $11M in October 2026 SEC filing
Altrartis Therapeutics
- Raised in SEC filings
- $11M
- Filings
- 1
- Latest est. round
- Series A
- Incorporated
- 2025
- Based in
- NY
Altrartis Therapeutics, a company incorporated in 2025, made its first SEC filing in October 2026. The filing reported an estimated Series A round with a first sale on August 12, 2026.
The company raised an estimated $11 million in this round. Florian Brand and Lars Christian Wilde are named in the latest filing. Find your role first does not yet track open roles for Altrartis Therapeutics.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-08-12 | $11M | Series A |
Named in the latest filing
- Florian Brand
- Lars Christian Wilde
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR